IDEXX Interest Income from 2010 to 2025

IDXX Stock

USD 418.11 5.49 1.30%

IDEXX Laboratories Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income is likely to outpace its year average in 2025. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-03-31

Previous Quarter

2.7 M

Current Value

2.2 M

Quarterly Volatility

2 M

Covid

Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 136.4 M, Interest Expense of 32.8 M or Total Revenue of 4.1 B, as well as many indicators such as Price To Sales Ratio of 9.17, Dividend Yield of 0.0 or PTB Ratio of 22.4. IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.

Check out the analysis of IDEXX Laboratories Correlation against competitors.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Latest IDEXX Laboratories' Interest Income Growth Pattern

Below is the plot of the Interest Income of IDEXX Laboratories over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. IDEXX Laboratories' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IDEXX Laboratories' overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

IDEXX Interest Income Regression Statistics

	Arithmetic Mean	12,591,559
	Geometric Mean	5,271,799
	Coefficient Of Variation	95.12
	Mean Deviation	10,740,809
	Median	12,699,000
	Standard Deviation	11,976,504
	Sample Variance	143.4T
	Range	26.3M
	R-Value	(0.71)
	Mean Square Error	76.2T
	R-Squared	0.50
	Significance	0
	Slope	(1,786,526)
	Total Sum of Squares	2151.5T

IDEXX Interest Income History

	2025	13.3 M
	2024	12.7 M
	2023	2.2 M
	2022	1.1 M
	2021	434 K
	2020	586 K
	2019	427 K

Other Fundumenentals of IDEXX Laboratories

Net Interest Income

IDEXX Laboratories Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.78	0.1	0.92	0.96	0.98	0.79	0.97	0.77	0.04	0.55	-0.9	0.98	0.59	0.84	0.57	0.06	0.72	0.87	-0.58	-0.44	0.76	0.77	0.63	0.68
Total Stockholder Equity	0.78		-0.51	0.93	0.66	0.74	0.23	0.73	0.7	-0.42	0.19	-0.62	0.71	0.12	0.62	-0.01	0.47	0.21	0.54	-0.73	-0.4	0.72	0.86	0.69	0.72
Net Debt	0.1	-0.51		-0.24	0.24	0.16	0.66	0.13	-0.02	0.76	0.43	-0.25	0.15	0.57	0.22	0.75	-0.56	0.59	0.31	0.33	0.11	-0.03	-0.28	-0.24	-0.3
Retained Earnings	0.92	0.93	-0.24		0.84	0.89	0.52	0.85	0.79	-0.19	0.32	-0.81	0.88	0.37	0.76	0.25	0.29	0.45	0.74	-0.72	-0.39	0.81	0.83	0.6	0.76
Accounts Payable	0.96	0.66	0.24	0.84		0.97	0.84	0.89	0.77	0.09	0.54	-0.92	0.97	0.67	0.88	0.66	0.07	0.78	0.9	-0.59	-0.46	0.69	0.67	0.52	0.62
Net Receivables	0.98	0.74	0.16	0.89	0.97		0.79	0.91	0.76	0.01	0.51	-0.92	0.97	0.65	0.88	0.62	0.16	0.74	0.9	-0.67	-0.49	0.77	0.74	0.63	0.62
Total Liab	0.79	0.23	0.66	0.52	0.84	0.79		0.79	0.51	0.47	0.67	-0.79	0.82	0.8	0.71	0.89	-0.36	0.92	0.82	-0.18	-0.29	0.47	0.36	0.3	0.35
Total Current Assets	0.97	0.73	0.13	0.85	0.89	0.91	0.79		0.71	0.17	0.6	-0.82	0.9	0.52	0.77	0.55	-0.06	0.7	0.8	-0.4	-0.33	0.7	0.76	0.65	0.63
Intangible Assets	0.77	0.7	-0.02	0.79	0.77	0.76	0.51	0.71		0.04	0.61	-0.8	0.73	0.39	0.88	0.27	0.31	0.43	0.71	-0.49	-0.23	0.7	0.66	0.39	0.37
Short Term Debt	0.04	-0.42	0.76	-0.19	0.09	0.01	0.47	0.17	0.04		0.43	-0.08	0.01	0.16	0.07	0.32	-0.73	0.23	0.06	0.59	0.61	0.06	-0.29	-0.45	-0.21
Common Stock	0.55	0.19	0.43	0.32	0.54	0.51	0.67	0.6	0.61	0.43		-0.65	0.54	0.61	0.63	0.56	-0.24	0.57	0.54	0.05	-0.2	0.22	0.2	0.2	0.0
Treasury Stock	-0.9	-0.62	-0.25	-0.81	-0.92	-0.92	-0.79	-0.82	-0.8	-0.08	-0.65		-0.91	-0.78	-0.9	-0.66	-0.15	-0.74	-0.88	0.58	0.52	-0.65	-0.61	-0.52	-0.46
Property Plant Equipment	0.98	0.71	0.15	0.88	0.97	0.97	0.82	0.9	0.73	0.01	0.54	-0.91		0.68	0.84	0.64	0.04	0.78	0.9	-0.61	-0.51	0.7	0.68	0.56	0.67
Current Deferred Revenue	0.59	0.12	0.57	0.37	0.67	0.65	0.8	0.52	0.39	0.16	0.61	-0.78	0.68		0.69	0.89	-0.14	0.87	0.79	-0.34	-0.59	0.31	0.27	0.37	0.06
Good Will	0.84	0.62	0.22	0.76	0.88	0.88	0.71	0.77	0.88	0.07	0.63	-0.9	0.84	0.69		0.58	0.19	0.71	0.93	-0.57	-0.39	0.77	0.72	0.53	0.26
Long Term Debt	0.57	-0.01	0.75	0.25	0.66	0.62	0.89	0.55	0.27	0.32	0.56	-0.66	0.64	0.89	0.58		-0.28	0.95	0.74	-0.15	-0.49	0.22	0.21	0.34	0.09
Net Tangible Assets	0.06	0.47	-0.56	0.29	0.07	0.16	-0.36	-0.06	0.31	-0.73	-0.24	-0.15	0.04	-0.14	0.19	-0.28		-0.25	0.03	-0.65	-0.43	0.11	0.28	0.36	0.16
Long Term Debt Total	0.72	0.21	0.59	0.45	0.78	0.74	0.92	0.7	0.43	0.23	0.57	-0.74	0.78	0.87	0.71	0.95	-0.25		0.88	-0.27	-0.51	0.41	0.44	0.47	0.22
Capital Surpluse	0.87	0.54	0.31	0.74	0.9	0.9	0.82	0.8	0.71	0.06	0.54	-0.88	0.9	0.79	0.93	0.74	0.03	0.88		-0.57	-0.47	0.74	0.71	0.58	0.32
Deferred Long Term Liab	-0.58	-0.73	0.33	-0.72	-0.59	-0.67	-0.18	-0.4	-0.49	0.59	0.05	0.58	-0.61	-0.34	-0.57	-0.15	-0.65	-0.27	-0.57		0.59	-0.6	-0.6	-0.55	-0.51
Short Long Term Debt	-0.44	-0.4	0.11	-0.39	-0.46	-0.49	-0.29	-0.33	-0.23	0.61	-0.2	0.52	-0.51	-0.59	-0.39	-0.49	-0.43	-0.51	-0.47	0.59		-0.04	-0.39	-0.7	-0.31
Long Term Investments	0.76	0.72	-0.03	0.81	0.69	0.77	0.47	0.7	0.7	0.06	0.22	-0.65	0.7	0.31	0.77	0.22	0.11	0.41	0.74	-0.6	-0.04		0.79	0.46	0.4
Net Invested Capital	0.77	0.86	-0.28	0.83	0.67	0.74	0.36	0.76	0.66	-0.29	0.2	-0.61	0.68	0.27	0.72	0.21	0.28	0.44	0.71	-0.6	-0.39	0.79		0.84	0.46
Net Working Capital	0.63	0.69	-0.24	0.6	0.52	0.63	0.3	0.65	0.39	-0.45	0.2	-0.52	0.56	0.37	0.53	0.34	0.36	0.47	0.58	-0.55	-0.7	0.46	0.84		0.34
Capital Stock	0.68	0.72	-0.3	0.76	0.62	0.62	0.35	0.63	0.37	-0.21	0.0	-0.46	0.67	0.06	0.26	0.09	0.16	0.22	0.32	-0.51	-0.31	0.4	0.46	0.34

Click cells to compare fundamentals

About IDEXX Laboratories Financial Statements

IDEXX Laboratories investors use historical fundamental indicators, such as IDEXX Laboratories' Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Interest Income	12.7 M	13.3 M
Net Interest Income	-18.5 M	-19.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IDEXX Interest Income from 2010 to 2025

Latest IDEXX Laboratories' Interest Income Growth Pattern

IDEXX Interest Income Regression Statistics

IDEXX Interest Income History

Other Fundumenentals of IDEXX Laboratories

IDEXX Laboratories Interest Income component correlations

About IDEXX Laboratories Financial Statements

Also Currently Popular

Additional Tools for IDEXX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY